Metrics Cost-effectiveness Analysis of Rivaroxaban versus Acenocoumarol in the Prevention of Stroke in Patients with Non-valvular Atrial Fibrillation in Spain
Cost-effectiveness Analysis of Rivaroxaban versus Acenocoumarol in the Prevention of Stroke in Patients with Non-valvular Atrial Fibrillation in Spain
Pageviews and PDF downloads
Top Countries | |
---|---|
34 | |
32 | |
27 | |
25 | |
13 | |
7 | |
5 | |
4 | |
3 | |
3 |